Food, Chemical & Pharmaceutical Law

• quarterly
• 70 pages
• 2511-7157
• 2511-7157

• More about this journal
• Order subscription
• Sign up for newsletter
• Get notifications about new releases

The European Pharmaceutical Law Review (EPLR) identifies and analyses important legal and regulatory developments on the national, EU and international level. It is primarily concerned with pharmaceutical law, medicines law and issues related to the work of the European Medicines Agency (EMA).

Furthermore, it provides an overview of and critically examines judgments and directives that shape the interpretation and application of EU pharmaceutical law and policy, including those by the European Medicines Agency (EMA), European Courts, international courts and tribunals such as the WTO’s Dispute Settlement Body, and higher national courts.

• quarterly
• 70 pages
• 2566-834X
• 2566-834X

• More about this journal
• Order subscription
• Sign up for newsletter
• Get notifications about new releases

Although it has been 10 years since the ground breaking EU REACH regulation came into force and fundamentally changed the way chemical substances are regulated, evaluated and authorised, this dynamic and ever changing policy area merits continuous scrutiny and analysis.

To provide a forum which will enable practitioners, regulators, policy makers and academics to discuss the most pressing issues in this field – in Europe and beyond – Lexxion has created the International Chemical Regulatory Law Review (ICRL).

Chemical law experts will report on key regulatory and legislative developments, not just in regard to EU REACH but also across the globe, and will analyse important processes that shape the interpretation and application of chemical regulation. Those relating to the international progress of chemicals registration, authorisation and restriction and the improvement of human health and environmental protection will be receive particular attention.